Concepts (132)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Electronic Nicotine Delivery Systems | 6 | 2023 | 46 | 2.370 |
Why?
|
| Diet, High-Fat | 2 | 2020 | 46 | 1.340 |
Why?
|
| Nicotine | 6 | 2024 | 91 | 1.330 |
Why?
|
| RNA-Binding Proteins | 3 | 2023 | 10 | 1.230 |
Why?
|
| Apoptosis Regulatory Proteins | 3 | 2023 | 11 | 1.230 |
Why?
|
| Apoptosis | 3 | 2020 | 117 | 0.950 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 2 | 2024 | 28 | 0.850 |
Why?
|
| Cotinine | 3 | 2020 | 19 | 0.830 |
Why?
|
| Endoribonucleases | 1 | 2023 | 4 | 0.820 |
Why?
|
| Animals | 13 | 2024 | 1369 | 0.770 |
Why?
|
| Mice | 7 | 2024 | 555 | 0.750 |
Why?
|
| Myocytes, Cardiac | 2 | 2020 | 22 | 0.730 |
Why?
|
| Mice, Obese | 1 | 2020 | 16 | 0.690 |
Why?
|
| Myocardium | 1 | 2020 | 19 | 0.690 |
Why?
|
| Heart | 1 | 2020 | 21 | 0.690 |
Why?
|
| Smoking | 1 | 2020 | 59 | 0.670 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2020 | 62 | 0.670 |
Why?
|
| Fatty Liver | 2 | 2024 | 52 | 0.650 |
Why?
|
| Mice, Inbred C57BL | 6 | 2024 | 196 | 0.640 |
Why?
|
| Diet, Western | 1 | 2019 | 5 | 0.620 |
Why?
|
| Liver Cirrhosis | 1 | 2019 | 51 | 0.590 |
Why?
|
| Oxidative Stress | 5 | 2024 | 92 | 0.570 |
Why?
|
| Fibroblasts | 2 | 2014 | 20 | 0.410 |
Why?
|
| Male | 7 | 2024 | 2620 | 0.410 |
Why?
|
| Cellular Senescence | 2 | 2014 | 6 | 0.330 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2020 | 11 | 0.330 |
Why?
|
| Nicotinic Agonists | 2 | 2019 | 24 | 0.310 |
Why?
|
| Vaping | 2 | 2019 | 20 | 0.310 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2008 | 23 | 0.300 |
Why?
|
| Humans | 6 | 2023 | 4931 | 0.250 |
Why?
|
| Disease Models, Animal | 3 | 2019 | 149 | 0.230 |
Why?
|
| Niacinamide | 1 | 2024 | 5 | 0.220 |
Why?
|
| Pyridinium Compounds | 1 | 2024 | 6 | 0.220 |
Why?
|
| Primate Diseases | 2 | 2013 | 2 | 0.210 |
Why?
|
| Hep G2 Cells | 1 | 2023 | 6 | 0.210 |
Why?
|
| Palmitates | 1 | 2023 | 5 | 0.210 |
Why?
|
| Fatty Acids | 1 | 2023 | 19 | 0.210 |
Why?
|
| Picornaviridae | 2 | 2012 | 2 | 0.200 |
Why?
|
| Picornaviridae Infections | 2 | 2012 | 2 | 0.200 |
Why?
|
| Mice, Knockout | 2 | 2019 | 112 | 0.190 |
Why?
|
| DNA Damage | 2 | 2014 | 15 | 0.190 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2019 | 11 | 0.180 |
Why?
|
| Blotting, Western | 2 | 2019 | 86 | 0.180 |
Why?
|
| Macaca mulatta | 2 | 2013 | 8 | 0.180 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2020 | 21 | 0.170 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2020 | 9 | 0.170 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2020 | 18 | 0.170 |
Why?
|
| Echocardiography | 1 | 2020 | 14 | 0.170 |
Why?
|
| Heart Ventricles | 1 | 2020 | 15 | 0.170 |
Why?
|
| Animals, Newborn | 1 | 2020 | 76 | 0.170 |
Why?
|
| Aerosols | 1 | 2019 | 11 | 0.160 |
Why?
|
| Pregnancy | 1 | 2020 | 417 | 0.160 |
Why?
|
| Behavior, Animal | 1 | 2019 | 28 | 0.160 |
Why?
|
| Biopsy, Needle | 1 | 2019 | 10 | 0.160 |
Why?
|
| Stroke Volume | 1 | 2019 | 19 | 0.160 |
Why?
|
| Ventricular Function, Left | 1 | 2019 | 17 | 0.160 |
Why?
|
| Random Allocation | 1 | 2019 | 18 | 0.160 |
Why?
|
| Analysis of Variance | 1 | 2019 | 53 | 0.150 |
Why?
|
| Atherosclerosis | 1 | 2019 | 26 | 0.150 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 98 | 0.150 |
Why?
|
| RNA, Viral | 3 | 2013 | 6 | 0.150 |
Why?
|
| Feces | 2 | 2012 | 6 | 0.130 |
Why?
|
| Female | 2 | 2020 | 2964 | 0.120 |
Why?
|
| Bangladesh | 5 | 2013 | 5 | 0.120 |
Why?
|
| Telomeric Repeat Binding Protein 2 | 1 | 2014 | 1 | 0.110 |
Why?
|
| Stromal Cells | 1 | 2014 | 5 | 0.110 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2014 | 6 | 0.110 |
Why?
|
| Skin | 1 | 2014 | 7 | 0.110 |
Why?
|
| DNA, Mitochondrial | 2 | 2019 | 7 | 0.110 |
Why?
|
| Virus Latency | 1 | 2013 | 1 | 0.110 |
Why?
|
| Simian foamy virus | 1 | 2013 | 1 | 0.110 |
Why?
|
| Proviruses | 1 | 2013 | 2 | 0.110 |
Why?
|
| Retroviridae Infections | 1 | 2013 | 2 | 0.110 |
Why?
|
| Transcription, Genetic | 1 | 2013 | 28 | 0.110 |
Why?
|
| Primates | 1 | 2012 | 2 | 0.100 |
Why?
|
| Genetic Variation | 1 | 2012 | 31 | 0.100 |
Why?
|
| Phylogeny | 2 | 2012 | 15 | 0.090 |
Why?
|
| Influenza in Birds | 1 | 2011 | 1 | 0.090 |
Why?
|
| Influenza A Virus, H5N1 Subtype | 1 | 2011 | 1 | 0.090 |
Why?
|
| Influenza A Virus, H9N2 Subtype | 1 | 2011 | 1 | 0.090 |
Why?
|
| Commerce | 1 | 2011 | 3 | 0.090 |
Why?
|
| Birds | 1 | 2011 | 4 | 0.090 |
Why?
|
| HeLa Cells | 1 | 2008 | 12 | 0.080 |
Why?
|
| DNA Repair | 1 | 2008 | 7 | 0.080 |
Why?
|
| Microsatellite Repeats | 1 | 2007 | 2 | 0.070 |
Why?
|
| Polymorphism, Genetic | 1 | 2007 | 8 | 0.070 |
Why?
|
| Molecular Sequence Data | 3 | 2012 | 48 | 0.070 |
Why?
|
| Sequence Analysis, DNA | 3 | 2012 | 14 | 0.070 |
Why?
|
| High Fructose Corn Syrup | 1 | 2024 | 5 | 0.060 |
Why?
|
| Lipolysis | 1 | 2023 | 11 | 0.050 |
Why?
|
| Phenotype | 1 | 2023 | 62 | 0.050 |
Why?
|
| Liver | 1 | 2024 | 139 | 0.050 |
Why?
|
| Cytokines | 1 | 2023 | 60 | 0.050 |
Why?
|
| Molecular Epidemiology | 2 | 2012 | 3 | 0.050 |
Why?
|
| Serotyping | 2 | 2012 | 2 | 0.050 |
Why?
|
| Cluster Analysis | 2 | 2012 | 8 | 0.040 |
Why?
|
| Apolipoproteins E | 1 | 2019 | 5 | 0.040 |
Why?
|
| Inhalation Exposure | 1 | 2019 | 8 | 0.040 |
Why?
|
| Mice, Knockout, ApoE | 1 | 2019 | 5 | 0.040 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2019 | 19 | 0.040 |
Why?
|
| Transcriptome | 1 | 2019 | 15 | 0.040 |
Why?
|
| Reactive Oxygen Species | 1 | 2019 | 33 | 0.040 |
Why?
|
| Mutation | 1 | 2019 | 51 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2014 | 13 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2014 | 18 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2014 | 21 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2014 | 17 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 72 | 0.030 |
Why?
|
| Gene Products, gag | 1 | 2013 | 1 | 0.030 |
Why?
|
| Cheek | 1 | 2013 | 2 | 0.030 |
Why?
|
| Virus Replication | 1 | 2013 | 6 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2013 | 11 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2014 | 127 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2014 | 164 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2014 | 51 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2014 | 101 | 0.030 |
Why?
|
| Neoplasms | 1 | 2014 | 66 | 0.030 |
Why?
|
| Animals, Zoo | 1 | 2012 | 1 | 0.030 |
Why?
|
| Viral Structural Proteins | 1 | 2012 | 1 | 0.030 |
Why?
|
| Sequence Homology | 1 | 2012 | 1 | 0.030 |
Why?
|
| Haplorhini | 1 | 2012 | 2 | 0.030 |
Why?
|
| Zoonoses | 1 | 2012 | 2 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2012 | 31 | 0.030 |
Why?
|
| Hemagglutination | 1 | 2011 | 2 | 0.020 |
Why?
|
| Geography | 1 | 2011 | 4 | 0.020 |
Why?
|
| Prevalence | 1 | 2011 | 184 | 0.020 |
Why?
|
| Haplotypes | 1 | 2007 | 2 | 0.020 |
Why?
|
| Likelihood Functions | 1 | 2007 | 3 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2007 | 3 | 0.020 |
Why?
|
| DNA Primers | 1 | 2007 | 16 | 0.020 |
Why?
|
| Base Sequence | 1 | 2007 | 35 | 0.020 |
Why?
|
| Demography | 1 | 2007 | 19 | 0.020 |
Why?
|